Pathogen management method and system based on gene sequencing
Through gene sequencing technology, the data on pathogen samples and clinical environment are collected and analyzed, and the transmission risk and dynamic prediction models are constructed, which solves the problem of insufficient understanding of pathogen transmission, pathogenicity and drug resistance in the existing technology, and achieves a more accurate pathogen Management and public health response.
Patent Information
- Application Number
- CN202411078809.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-22
AI Technical Summary
The existing pathogen management methods rely on clinical trials and experience, and the lack of in-depth analysis of the genetic characteristics of pathogens has limited understanding and predictive capabilities for pathogen transmission, pathogenicity and drug resistance, which is difficult to meet the needs of modern pathogen management.
Gene sequencing is used to collect pathogen samples and clinical environment data, extract key gene characteristics, build transmission risk and dynamic prediction models, formulate targeted management strategies, and improve the effectiveness of decision-making and the speed and effectiveness of public health response.
Rapidly identify pathogen species and variants through gene sequencing technology, provide detailed genetic information of pathogens, quantify transmission risks, predict epidemic trends, formulate refined management strategies, reduce drug resistance development, and improve the efficiency of the use of public health resources and public trust.
Smart Images

Figure CN119008033A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of pathogen management, and in particular to a pathogen management method and system based on gene sequencing. Background Art
[0002] Against the backdrop of a global population explosion and rapid urbanization, food safety and public health systems are facing unprecedented challenges, with frequent outbreaks of diseases caused by pathogens, which mainly include bacteria, viruses, fungi, parasites, etc. Pathogens are transmitted through different routes, including air droplets, food and water, contact, insect bites, blood and sexual transmission. Various diseases caused by pathogens not only pose a serious threat to human health, but also pose challenges to social stability that cannot be ignored.
[0003] Existing pathogen management methods mainly rely on clinical trials and experience, and lack in-depth analysis of the genetic characteristics of pathogens, resulting in limited understanding and prediction of pathogen transmission, pathogenicity and drug resistance, which is difficult to meet the needs of modern pathogen management. Summary of the invention
[0004] In order to solve the above technical problems, the present invention provides a pathogen management method and system based on gene sequencing, which can improve the effectiveness and pertinence of decision-making, provide comprehensive and accurate information, and thus improve the speed and effectiveness of public health response.
[0005] In a first aspect, the present invention provides a pathogen management method based on gene sequencing, the method comprising:
[0006] Collect genetic sequencing data information of pathogen samples and clinical environment data information;
[0007] Extract key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information;
[0008] Input key gene features into a pre-built transmission risk analysis model to obtain pathogen transmission risk factors;
[0009] Extracting the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, wherein the clinical environment propagation characteristics of the pathogen include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation;
[0010] The pathogen transmission risk factors and the pathogen clinical environment transmission characteristics are used as inputs to the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future;
[0011] Develop corresponding pathogen management strategies based on the pathogen epidemic trend guidance parameters.
[0012] Furthermore, the method for collecting gene sequencing data information includes:
[0013] Determine the type of sample that needs to be collected based on the purpose of the study and the characteristics of the pathogen;
[0014] Based on the principle of aseptic operation, use sampling tools and containers to collect samples and record detailed sampling information;
[0015] extracting nucleic acid from the sample and performing quality assessment on the extracted nucleic acid;
[0016] The extracted nucleic acid is fragmented and a sequencing adapter is added to construct a sequencing library;
[0017] Use a sequencer to perform sequencing reactions on the data in the sequencing library to generate gene sequencing data information.
[0018] Furthermore, the method for collecting clinical environment data information includes:
[0019] Identify and determine sources of clinical environmental data, including hospital medical record systems, CDC records, and environmental monitoring reports;
[0020] Extract clinical environment data from various data sources;
[0021] Clean the extracted data to remove duplicate, erroneous and irrelevant information, and organize the data into a unified format;
[0022] The cleaned and organized data is stored in the database.
[0023] Furthermore, the method for extracting the key gene features includes:
[0024] Perform quality control on gene sequencing data information to remove low-quality, noisy and erroneous data;
[0025] Detecting the variation type in the gene sequencing data information, comparing the detected variation type with the known variation, and obtaining gene variation data;
[0026] Feature selection is performed on genetic variation data to identify key genetic features that have the greatest impact on pathogen characteristics.
[0027] Furthermore, the mathematical calculation formula of the transmission risk analysis model is:
[0028] R=β0+β1X1+β2X2+…+β n X n +∈;
[0029] Among them, R represents the transmission risk factor of the pathogen, β0 represents the intercept term of the model, β1,β2,…,βn is the coefficient of the corresponding feature, indicating the impact of these features on the risk of transmission, X1, X2,…, X n represents the key genetic features that affect the risk of transmission, and ∈ is the error term, which represents the factors that the model fails to capture.
[0030] Furthermore, the method for extracting the clinical environment transmission characteristics of pathogens includes:
[0031] Clean and preprocess clinical environment data information to remove duplicate, erroneous and irrelevant information;
[0032] Identify seasonal, cyclical, and sudden patterns of pathogen infection;
[0033] Through patient information in case reports, demographic characteristics were extracted and the relationship between demographic characteristics and pathogen infection risk was analyzed;
[0034] Analyze the basic health status, comorbidities, and immune status of the infected population based on electronic medical records and questionnaires;
[0035] Analyze the living habits, social behaviors, and medical contacts of infected people to identify transmission risk factors;
[0036] The extracted features are integrated to obtain the clinical environment transmission characteristics of the pathogen.
[0037] Furthermore, the mathematical calculation formula of the pathogen dynamic prediction model is:
[0038]
[0039] in, represents the epidemic trend guidance parameter of the pathogen within the future set time, X represents the input feature matrix containing the pathogen transmission risk factor and the pathogen clinical environment transmission characteristics, T i represents the i-th decision tree, and N represents the number of decision trees in the random forest.
[0040] Furthermore, the pathogen management strategy includes:
[0041] Quantify the risk of pathogen transmission and prioritize pathogens based on epidemic trend guidance parameters;
[0042] Develop early warning and response plans based on risk assessment results;
[0043] Strengthen the construction of surveillance networks based on the transmission pathways and characteristics of pathogens;
[0044] Implement intervention and control measures based on the transmission mode and characteristics of the pathogen;
[0045] In the process of implementing management strategies, continuously collect and analyze epidemic data to evaluate the effectiveness and feasibility of the strategies; adjust and optimize management strategies in a timely manner based on the evaluation results.
[0046] Furthermore, the gene sequencing data information includes genome sequence data, gene variation data, gene expression profile data, drug resistance-related gene data, metabolic pathways and functional annotations.
[0047] On the other hand, the present application also provides a pathogen management system based on gene sequencing, the system comprising:
[0048] The sample collection and processing module collects genetic sequencing data information of pathogen samples and clinical environment data information;
[0049] Gene feature extraction module, which extracts key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information;
[0050] The transmission risk analysis module inputs key gene features into a pre-built transmission risk analysis model to obtain pathogen transmission risk factors;
[0051] The clinical environment data analysis module extracts the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, which include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation;
[0052] The pathogen dynamic prediction module takes the pathogen transmission risk factors and the pathogen clinical environment transmission characteristics as input into the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future;
[0053] The management strategy formulation module formulates corresponding pathogen management strategies based on the epidemic trend guidance parameters of pathogens.
[0054] Compared with the prior art, the present invention has the following beneficial effects: the method can quickly identify the type of pathogen and its mutation through gene sequencing technology, which helps to timely discover newly emerged pathogens or mutants and achieve early warning;
[0055] Gene sequencing provides a detailed view of the genetic information of the pathogen, helps to distinguish different strains of the pathogen and can identify emerging variants;
[0056] Transmission risk analysis models can quantify the transmission potential of pathogens and, combined with key genetic characteristics, can assess the risk level of different regions or populations, thereby prioritizing areas that require enhanced surveillance or intervention;
[0057] The pathogen dynamic prediction model uses pathogen transmission risk factors and clinical environment transmission characteristics to predict the epidemic trend of pathogens in the future, which helps to plan resource allocation and formulate intervention measures in advance;
[0058] By comprehensively considering the characteristics of pathogens and specific environmental conditions, more refined management strategies can be formulated; understanding the characteristics of pathogen resistance can help reduce unnecessary use of antibiotics, slow the development of resistance, and protect public health resources; the application of scientific data support and predictive models can increase public trust in public health measures and promote cooperation and coordination;
[0059] This method can be quickly adjusted according to the emergence of new pathogens or changes in existing pathogens, maintaining the flexibility and adaptability of the system; by collecting and analyzing large amounts of data, it can support evidence-based decision-making processes and improve the effectiveness and pertinence of decisions; it can provide more comprehensive and accurate information, helping to improve the speed and effectiveness of public health responses. BRIEF DESCRIPTION OF THE DRAWINGS
[0060] Figure 1 is a flow chart of the present invention;
[0061] Figure 2 is a flow chart of the pathogen management strategy;
[0062] Figure 3 It is a structural diagram of a pathogen management method and system based on gene sequencing. DETAILED DESCRIPTION
[0063] The present application describes the provided method and system through flowcharts and / or block diagrams.
[0064] The present application is described below in conjunction with the drawings in the present application.
[0065] Embodiment 1: Figure 1 to Figure 2 As shown, a pathogen management method based on gene sequencing of the present invention specifically includes the following steps:
[0066] S1. Collect genetic sequencing data information of pathogen samples and clinical environment data information;
[0067] The method for collecting gene sequencing data information comprises:
[0068] Determine the type of sample that needs to be collected based on the purpose of the study and the characteristics of the pathogen;
[0069] Follow the principle of aseptic operation and use appropriate sampling tools and containers to collect samples; ensure that the samples are not contaminated during the collection process and record detailed sampling information;
[0070] Extract nucleic acids from samples and conduct quality assessment on the extracted nucleic acids to ensure that their concentration, purity, and integrity meet sequencing requirements;
[0071] The extracted nucleic acid is fragmented and a sequencing adapter is added to construct a sequencing library;
[0072] Using a sequencer to perform sequencing reaction on the data in the sequencing library to generate gene sequencing data information;
[0073] The gene sequencing data information includes:
[0074] Genome sequence data: The most basic gene sequencing data, which contains the complete DNA and RNA sequences of the pathogen; through whole genome sequencing, all genetic information of the pathogen can be obtained;
[0075] Genetic variation data: By comparing sequence differences between different samples, single nucleotide polymorphisms, insertions / deletions, copy number variations and other variation types can be identified; these variations affect the pathogen's ability to spread, virulence and sensitivity to antibiotics;
[0076] Gene expression profile data: Transcriptome sequencing can be used to obtain the gene expression levels of pathogens under specific conditions, which helps to understand how pathogens adapt to the host environment and survive in it;
[0077] Resistance-related gene data: For antibiotic resistance, the resistance potential of pathogens can be assessed by detecting specific resistance genes;
[0078] Metabolic pathways and functional annotation: Bioinformatics analysis of the genome enables inference of the pathogen’s metabolic pathways and potential functions; thereby understanding the pathogen’s growth conditions and nutritional requirements, and how it exploits these pathways to facilitate the infection process;
[0079] The method for collecting clinical environment data information includes:
[0080] Identify and determine the primary sources of clinical environmental data, including hospital medical record systems, CDC records, and environmental monitoring reports;
[0081] Extract required data from various data sources;
[0082] Clean the extracted data to remove duplicate, erroneous and irrelevant information;
[0083] Organize the data into a unified format to facilitate subsequent analysis and processing;
[0084] Store the cleaned and organized data into a database;
[0085] Establish data management mechanisms to ensure data security, reliability and accessibility;
[0086] Verify the collected data to ensure its accuracy and completeness;
[0087] Implement quality control measures, regular audits, data backup and recovery;
[0088] The clinical environment data information includes:
[0089] Geographic information: record where the pathogen was detected and where the affected population is located;
[0090] Demographic data: Understand basic information such as age, gender, occupation, etc.: Helps identify susceptible and high-risk groups; Understand population mobility to assess the spread of pathogens;
[0091] Epidemiological data: including the number of confirmed cases and suspected cases; recording the main symptoms of patients in order to identify typical symptom combinations; understanding the patient's recent travel activities, which helps track the source and transmission path of the pathogen; including close contact information and the patient's contact with known infected persons;
[0092] Environmental monitoring data: including temperature, humidity, etc., which affect the survival rate and transmission ability of pathogens; pathogens present in water may be transmitted to humans through drinking water or contact; testing for the presence of pathogens in food, especially for foodborne diseases; for pathogens transmitted by insects, monitoring the number and distribution of vector insects; for pathogens transmitted by air droplets, monitoring air quality helps assess the risk of transmission;
[0093] Socioeconomic data: Availability of sanitation facilities, including clean water, toilet facilities, etc.; poor areas often have poor sanitation, which may increase the risk of pathogen transmission;
[0094] Public health interventions: Understand vaccination coverage and the immune status of the population; record the frequency and methods of cleaning in public places; record the isolation of confirmed or suspected cases.
[0095] In this step, the quality of gene sequencing data is ensured by carefully selecting and strictly processing pathogen samples, thereby improving the credibility and effectiveness of the entire research project; gene sequencing data can reveal the genetic characteristics and variations of pathogens, which helps to gain a deeper understanding of the pathogenesis and development of the disease; clinical environment data combined with gene sequencing data can provide a more accurate basis for disease diagnosis and provide support for the design of individualized treatment plans; comprehensive analysis of these data can help identify disease transmission patterns, evaluate the effectiveness of intervention measures, and formulate more effective public health policies based on this; high-quality data sets can accelerate the development of new drugs; by establishing a strict data management mechanism, the security and integrity of data are ensured to avoid data loss or improper use; this step promotes cooperation between experts in multiple fields such as biology, medicine, and information technology to jointly promote scientific research and technological development; through rigorous data collection and processing procedures, it can not only significantly improve the reliability of scientific research results, but also provide strong support for practices in the fields of healthcare and public health, ultimately helping to improve public health and quality of life.
[0096] S2. Extract key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information;
[0097] The method for extracting the key gene features comprises:
[0098] Perform quality control on gene sequencing data information to remove low-quality, noisy and erroneous data to ensure the accuracy of subsequent analysis;
[0099] Compare the processed gene sequence with the reference genome to identify variant sites, insertions / deletions, and structural variations;
[0100] Use bioinformatics tools to detect single nucleotide polymorphisms and other types of variation in gene sequences;
[0101] Compare the types of variants detected with known variants in databases to identify specific variants associated with pathogen transmission, pathogenicity, and drug resistance;
[0102] Refer to existing literature and research results in databases to screen out gene regions that are known to be closely related to pathogen transmission, pathogenicity and drug resistance;
[0103] Use machine learning algorithms to perform feature selection on genetic variation data to identify genetic features that have the greatest impact on pathogen characteristics;
[0104] Validate the effects of selected genetic signatures on pathogen transmission, pathogenicity, and drug resistance through laboratory experiments;
[0105] Combined with clinical data, the correlation between the selected gene features and the actual manifestations of the pathogens was further verified.
[0106] In this step, the quality of gene sequencing data is controlled and low-quality data is removed to ensure the accuracy of subsequent analysis; specific gene variants closely related to pathogen characteristics are identified, which helps to improve the prediction accuracy of pathogen transmission, pathogenicity and drug resistance; the extraction of key gene features can help identify new variants or mutants of pathogens, help to detect potential transmission risks at an early stage, and take timely intervention measures; the discovery of key gene features provides targets for new drug development and helps to accelerate the drug development process; the application of gene sequencing technology and bioinformatics tools promotes cooperation in biology, medicine, computer science and other fields; feature selection through machine learning algorithms can quickly identify pathogens. The genetic features with the greatest impact on pathogen characteristics improve research efficiency; laboratory experiments verify the impact of the selected genetic features on pathogen transmission, pathogenicity and drug resistance, increasing the credibility of the research results; combined with clinical data to further verify the correlation between the selected genetic features and the actual manifestations of the pathogen, it is helpful to transform the research results into clinical applications; combining gene sequencing data with research results in existing literature and databases enhances the understanding of pathogen characteristics; using the latest bioinformatics tools and machine learning algorithms to promote technological innovation and methodological progress; step S2 can effectively identify key genetic features that affect pathogen transmission, pathogenicity and drug resistance through rigorous data processing and analysis processes.
[0107] S3, input key gene features into the pre-built transmission risk analysis model to obtain pathogen transmission risk factors;
[0108] The key gene features are input into the transmission risk analysis model. The model calculates the transmission risk factor of the pathogen based on the input gene features combined with its internal learning rules and algorithms.
[0109] The construction method of the transmission risk analysis model is:
[0110] Collect genetic sequencing data, clinical environment data, and transmission data of pathogens, and clean, organize, and standardize the collected data to eliminate noise, fill in missing values, and unify data formats;
[0111] Selecting machine learning models as the infrastructure of the transmission risk analysis model, the machine learning models include random forest, gradient boosting tree and neural network;
[0112] Divide the processed data into training set and validation set;
[0113] Use the training set to train the model so that it can learn the rules and patterns in the data; use the validation set to evaluate the model's predictive performance to ensure the accuracy and reliability of the model;
[0114] Evaluate the model based on the validation results to identify existing problems and deficiencies; optimize and adjust the model based on the evaluation results; regularly iterate and update the model as new data is generated and pathogen characteristics change to maintain the timeliness and accuracy of the model;
[0115] Deploy the constructed model into the system to obtain pathogen transmission risk factors in real time;
[0116] The mathematical calculation formula of the transmission risk analysis model is:
[0117] R=β0+β1X1+β2X2+…+β n X n +∈
[0118] Among them, R represents the transmission risk factor of the pathogen, β0 represents the intercept term of the model, β1,β2,…,β n is the coefficient of the corresponding feature, indicating the impact of these features on the risk of transmission, X1, X2,…, X n represents the key genetic features that affect the risk of transmission, and ∈ is the error term, which represents the factors that the model fails to capture.
[0119] In this step, by integrating the genetic sequencing data and clinical environment data of the pathogen, the transmission risk analysis model can accurately assess the transmission risk of the pathogen; it goes beyond traditional clinical trials and empirical judgments and provides a more scientific and quantitative evaluation method; the real-time acquisition of transmission risk factors provides strong data support for pathogen management; management departments can quickly formulate and adjust management strategies based on these risk factors, thereby improving management efficiency and effectiveness; because the model takes into account the genetic characteristics and clinical environmental factors of the pathogen, it can formulate personalized management strategies for different pathogens and different transmission environments; this customized strategy is more in line with the actual situation and helps to improve the prevention and control effect; the transmission risk analysis model adopts machine learning technology and has the ability to continuously learn and optimize; as new data is continuously generated and the characteristics of the pathogen change, the model can be iterated and updated regularly to maintain its timeliness and accuracy; the construction and application of the transmission risk analysis model not only provides a practical tool for pathogen management, but also promotes scientific research and technological innovation in related fields; through the continuous optimization and improvement of the model, it can promote in-depth research on the transmission mechanism and pathogenic mechanism of the pathogen.
[0120] S4. Extracting the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, wherein the clinical environment propagation characteristics of the pathogen include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation;
[0121] Methods for extracting pathogen transmission characteristics in clinical environments include:
[0122] Clean and pre-process clinical environment data information to remove duplicate, erroneous and irrelevant information to ensure data accuracy and completeness;
[0123] Use geographic information system technology to visualize pathogen infection case data on a map and analyze the spatial clustering and spread trends of cases;
[0124] Perform statistical analysis on time series data to identify seasonal, cyclical, and sudden patterns of pathogen infection;
[0125] Through patient information in case reports, demographic characteristics were extracted and the relationship between these characteristics and pathogen infection risk was analyzed;
[0126] Using electronic medical record systems and questionnaire survey data, we analyzed the basic health status, comorbidities, and immune status of the infected population to assess their impact on susceptibility to pathogen infection and disease severity;
[0127] Through epidemiological surveys, analyze the living habits, social behaviors, and medical contacts of infected people to identify potential transmission risk factors;
[0128] Collect and analyze physical parameters of the pathogen's environment and assess their impact on pathogen survival and spread;
[0129] Analyze chemicals present in the environment to assess their effects on pathogen survival and spread;
[0130] Study the interactions between pathogens and other organisms to identify potential vectors and synergistic agents;
[0131] The various features extracted above are integrated to form a complete clinical environment transmission feature of the pathogen.
[0132] In this step, the cleaning and preprocessing of clinical environmental data information ensured the accuracy and reliability of subsequent analysis and avoided misleading conclusions caused by data quality issues. The use of geographic information system technology to visualize pathogen infection cases not only intuitively demonstrated the spatial distribution and diffusion trend of cases, but also revealed the seasonal, cyclical and sudden change patterns of infection through time series analysis, providing an important basis for timely detection of epidemic outbreaks and formulation of response measures. Through detailed analysis of the demographic characteristics, health status, behavioral patterns, etc. of the infected population, we can have a deeper understanding of the susceptibility of different populations to pathogens and the severity of the disease, providing a scientific basis for precise prevention and control. A comprehensive assessment of the physical, chemical and biological factors of the pathogen's environment revealed the important role of environmental factors in the survival and spread of pathogens, which is helpful for the formulation of targeted environmental intervention measures to reduce the risk of pathogen transmission. The study of the interaction between pathogens and other organisms and the identification of potential transmission media and synergistic factors are helpful for a deep understanding of the transmission mechanism of pathogens and provide theoretical support for the formulation of comprehensive prevention and control strategies. The above-mentioned characteristics are integrated to form a complete set of pathogen clinical environmental transmission characteristics, which provides comprehensive and rich data input for subsequent prediction models and improves the accuracy and practicality of prediction models.
[0133] S5. Input the pathogen transmission risk factors and the pathogen clinical environment transmission characteristics into the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future;
[0134] Selecting a suitable machine learning model to build a pathogen dynamic prediction model; the machine learning model includes a random forest, a support vector machine, and a neural network;
[0135] Integrate pathogen transmission risk factors and pathogen transmission characteristics in clinical environments;
[0136] Divide the integrated dataset into training and testing sets;
[0137] The selected model is trained using the training set to learn the pattern of pathogen transmission;
[0138] Use the test set to evaluate the model's predictive performance and ensure the model's accuracy and reliability;
[0139] Adjust the model's hyperparameters through grid search, random search, and other methods to optimize model performance;
[0140] Use methods such as cross-validation to further evaluate the generalization ability of the model;
[0141] Taking pathogen transmission risk factors and pathogen transmission characteristics in clinical settings as input;
[0142] The model outputs guiding parameters for the epidemic trend of pathogens within a set period of time in the future;
[0143] The mathematical calculation formula of the pathogen dynamic prediction model is:
[0144]
[0145] in, represents the epidemic trend guidance parameter of the pathogen within the future set time, X represents the input feature matrix containing the pathogen transmission risk factor and the pathogen clinical environment transmission characteristics, T i represents the i-th decision tree, and N represents the number of decision trees in the random forest.
[0146] In this step, by leveraging the powerful learning and generalization capabilities of machine learning models, the complex relationship between pathogen transmission, pathogenicity and drug resistance can be captured more accurately, thereby improving the accuracy of predictions on future pathogen epidemic trends. The pathogen dynamic prediction model outputs the epidemic trend guidance parameters of pathogens within a set future time, which provides a scientific basis for decision-making for public health departments and related agencies. It helps to formulate and adjust pathogen management strategies in a timely manner to respond to potential epidemic outbreaks and public health crises. Based on accurate prediction results, public health departments can allocate resources more effectively to respond to disease challenges caused by different pathogens. By real-time monitoring and analysis of pathogen transmission risk factors and clinical environment transmission characteristics, the model can detect diseases in a timely manner. The prediction results can be adjusted quickly based on the changes in the pathogen transmission pattern, providing strong support for rapid response and effective control of the epidemic. The pathogen dynamic prediction model not only provides a powerful tool for practical applications, but also promotes scientific research on pathogen transmission mechanisms, pathogenicity and drug resistance. Accurate prediction of pathogen epidemic trends can help reduce public panic and uncertainty, improve society's ability to respond to public health events, and thus enhance social stability and public confidence. Step S5 builds a pathogen dynamic prediction model based on machine learning to achieve accurate prediction of future pathogen epidemic trends, providing scientific decision-making support for public health departments and related institutions, helping to optimize resource allocation, improve response speed, promote scientific research and enhance social stability.
[0147] S6. Develop corresponding pathogen management strategies based on pathogen epidemic trend guidance parameters;
[0148] Step S6 aims to transform the prediction results into practical action plans to effectively respond to the health threats and social challenges that pathogens may bring. The pathogen management strategies include:
[0149] Quantify the risk of pathogen transmission based on epidemic trend guidance parameters and prioritize different pathogens or the same pathogen in different regions; this helps decision-makers focus resources and prioritize those pathogens that are most likely to cause serious epidemics or have a major impact on society;
[0150] Develop detailed early warning and response plans based on risk assessment results; this includes establishing a rapid response mechanism to ensure that response measures can be quickly initiated at the early stage of pathogen transmission; developing emergency response plans at different levels to deal with epidemics of different scales and severity; and establishing cross-departmental and cross-regional collaboration mechanisms to ensure information sharing and coordinated actions;
[0151] Strengthen the construction of monitoring networks based on the transmission pathways and characteristics of pathogens to ensure timely detection and reporting of pathogen infection cases; this includes setting up monitoring points in key areas such as medical institutions, communities, schools, and food production sites, and using modern scientific and technological means to improve monitoring efficiency and accuracy; at the same time, establish unimpeded reporting channels to ensure that epidemic information can be uploaded and distributed in a timely manner to provide support for decision-making;
[0152] Implement targeted intervention and control measures based on the transmission mode and characteristics of the pathogen; including strengthening personal hygiene and public health publicity and education to enhance public awareness of self-protection; isolating and treating infected persons and close contacts; disinfecting contaminated environments and objects; strengthening food safety supervision to prevent the spread of pathogens through the food chain; and carrying out preventive measures such as vaccination;
[0153] In the process of implementing management strategies, continuously collect and analyze epidemic data to evaluate the effectiveness and feasibility of the strategies; based on the evaluation results, timely adjust and optimize management strategies to ensure that they can flexibly respond to changes in the epidemic.
[0154] In this step, through the quantitative assessment of the epidemic trend of pathogens, the risk priority of transmission of different pathogens or the same pathogen in different regions can be clarified, so as to help decision makers allocate resources scientifically and rationally, give priority to responding to high-risk pathogens, and ensure the effectiveness and pertinence of prevention and control measures; the established early warning and response plan provides a solid institutional guarantee for pathogen management; the rapid response mechanism can quickly initiate response measures at the early stage of pathogen transmission and effectively curb the spread of the epidemic; emergency plans at different levels and cross-departmental and cross-regional collaboration mechanisms ensure the flexibility and efficiency of epidemic response; strengthen the construction of monitoring networks, use modern scientific and technological means to improve monitoring efficiency and accuracy, and timely discover and report pathogen infection cases; help to grasp the dynamics of the epidemic and provide timely and accurate information support for decision-making; at the same time, unimpeded reporting channels ensure the rapid transmission of epidemic information and promote information sharing and coordinated actions; targeted intervention and control measures are implemented according to the transmission routes and characteristics of pathogens; in the process of implementing management strategies, focus on continuous collection and analysis of epidemic data to evaluate the effectiveness and feasibility of strategies; ensure that management strategies can flexibly respond to changes in the epidemic and constantly adapt to new prevention and control needs; help to maintain initiative and flexibility in the process of epidemic prevention and control and improve prevention and control effects.
[0155] Embodiment 2: Figure 3 As shown, a pathogen management system based on gene sequencing of the present invention specifically includes the following modules;
[0156] The sample collection and processing module collects genetic sequencing data information of pathogen samples and clinical environment data information;
[0157] Gene feature extraction module, which extracts key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information;
[0158] The transmission risk analysis module inputs key gene features into a pre-built transmission risk analysis model to obtain pathogen transmission risk factors;
[0159] The clinical environment data analysis module extracts the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, which include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation;
[0160] The pathogen dynamic prediction module takes the pathogen transmission risk factors and the pathogen clinical environment transmission characteristics as input into the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future;
[0161] The management strategy formulation module formulates corresponding pathogen management strategies based on the epidemic trend guidance parameters of pathogens.
[0162] The system can detect potential pathogen transmission risks earlier through rapid identification and analysis of pathogen genetic characteristics, thereby achieving early warning; gene sequencing technology makes pathogen identification more accurate, able to distinguish different strains and even detect newly emerging variants;
[0163] The Transmission Risk Analysis module quantifies the transmission potential of pathogens, helping public health departments more accurately assess the risk level of different areas;
[0164] The pathogen dynamic prediction module uses pathogen transmission risk factors and clinical environment transmission characteristics to predict the epidemic trend of pathogens in the future, which helps to plan resource allocation in advance;
[0165] By comprehensively considering the characteristics of pathogens and specific environmental conditions, more refined management strategies can be developed; understanding the characteristics of pathogen resistance can help reduce unnecessary use of antibiotics and slow the development of resistance; the use of scientific methods and technologies can increase public trust in public health measures and promote cooperation and coordination;
[0166] The system can be quickly adjusted according to the emergence of new pathogens or changes in existing pathogens, maintaining the flexibility and adaptability of the system; the system integrates knowledge from multiple fields such as molecular biology, epidemiology, and bioinformatics, which helps to form an interdisciplinary collaborative research model; by collecting and analyzing large amounts of data, it can support evidence-based decision-making processes and improve the effectiveness and pertinence of decisions;
[0167] In summary, compared with traditional management methods, the pathogen management system based on gene sequencing can provide more comprehensive and accurate information, which helps to improve the speed and effectiveness of public health response.
[0168] The various variations and specific embodiments of the pathogen management method based on gene sequencing in the aforementioned embodiment 1 are also applicable to the pathogen management system based on gene sequencing in this embodiment. Through the aforementioned detailed description of the pathogen management method based on gene sequencing, those skilled in the art can clearly understand the implementation method of the pathogen management system based on gene sequencing in this embodiment, so for the sake of brevity of the specification, it will not be described in detail here.
[0169] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the technical principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A pathogen management method based on gene sequencing, characterized in that: The method comprises: Collect genetic sequencing data information of pathogen samples and clinical environment data information; Extract key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information; Input key gene features into a pre-built transmission risk analysis model to obtain pathogen transmission risk factors; Extracting the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, wherein the clinical environment propagation characteristics of the pathogen include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation; The pathogen transmission risk factors and the pathogen clinical environment transmission characteristics are used as inputs to the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future; Develop corresponding pathogen management strategies based on the pathogen epidemic trend guidance parameters.
2. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: The method for collecting gene sequencing data information comprises: Determine the type of sample that needs to be collected based on the purpose of the study and the characteristics of the pathogen; Based on the principle of aseptic operation, use sampling tools and containers to collect samples and record detailed sampling information; extracting nucleic acid from the sample and performing quality assessment on the extracted nucleic acid; The extracted nucleic acid is fragmented and a sequencing adapter is added to construct a sequencing library; Use a sequencer to perform sequencing reactions on the data in the sequencing library to generate gene sequencing data information.
3. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: The method for collecting clinical environment data information includes: Identify and determine sources of clinical environmental data, including hospital medical record systems, CDC records, and environmental monitoring reports; Extract clinical environment data from various data sources; Clean the extracted data to remove duplicate, erroneous and irrelevant information, and organize the data into a unified format; The cleaned and organized data is stored in the database.
4. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: The method for extracting the key gene features comprises: Perform quality control on gene sequencing data information to remove low-quality, noisy and erroneous data; Detecting the variation type in the gene sequencing data information, comparing the detected variation type with the known variation, and obtaining gene variation data; Feature selection is performed on genetic variation data to identify key genetic features that have the greatest impact on pathogen characteristics.
5. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: The mathematical calculation formula of the transmission risk analysis model is: R=β0+β1X1+β2X2+…+β n X n +∈; Among them, R represents the transmission risk factor of the pathogen, β0 represents the intercept term of the model, β1,β2,…,β n is the coefficient of the corresponding feature, indicating the impact of these features on the risk of transmission, X1, X2,…, X n represents the key genetic features that affect the risk of transmission, and ∈ is the error term, which represents the factors that the model fails to capture.
6. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: Methods for extracting pathogen transmission characteristics in clinical environments include: Clean and preprocess clinical environment data information to remove duplicate, erroneous and irrelevant information; Identify seasonal, cyclical, and sudden patterns of pathogen infection; Through patient information in case reports, demographic characteristics were extracted and the relationship between demographic characteristics and pathogen infection risk was analyzed; Analyze the basic health status, comorbidities, and immune status of the infected population based on electronic medical records and questionnaires; Analyze the living habits, social behaviors, and medical contacts of infected people to identify transmission risk factors; The extracted features are integrated to obtain the clinical environment transmission characteristics of the pathogen.
7. A pathogen management method based on gene sequencing as claimed in claim 1, characterized in that: The mathematical calculation formula of the pathogen dynamic prediction model is: in, represents the epidemic trend guidance parameter of the pathogen within the future set time, X represents the input feature matrix containing the pathogen transmission risk factor and the pathogen clinical environment transmission characteristics, T i represents the i-th decision tree, and N represents the number of decision trees in the random forest.
8. The pathogen management method based on gene sequencing according to claim 1, characterized in that: The pathogen management strategies include: Quantify the risk of pathogen transmission and prioritize pathogens based on epidemic trend guidance parameters; Develop early warning and response plans based on risk assessment results; Strengthen the construction of surveillance networks based on the transmission pathways and characteristics of pathogens; Implement intervention and control measures based on the transmission mode and characteristics of the pathogen; In the process of implementing management strategies, continuously collect and analyze epidemic data to evaluate the effectiveness and feasibility of the strategies; adjust and optimize management strategies in a timely manner based on the evaluation results.
9. A pathogen management method based on gene sequencing as claimed in claim 2, characterized in that: The gene sequencing data information includes genome sequence data, gene variation data, gene expression profile data, drug resistance-related gene data, metabolic pathways and functional annotations.
10. A pathogen management system based on gene sequencing, characterized in that: The system comprises: The sample collection and processing module collects genetic sequencing data information of pathogen samples and clinical environment data information; Gene feature extraction module, which extracts key gene features that affect pathogen transmission, pathogenicity and drug resistance from gene sequencing data information; The transmission risk analysis module inputs key gene features into a pre-built transmission risk analysis model to obtain pathogen transmission risk factors; The clinical environment data analysis module extracts the propagation characteristics of the clinical environment data information to obtain the clinical environment propagation characteristics of the pathogen, which include the distribution characteristics of the pathogen, the characteristics of the infected population, and the characteristics of environmental adaptation; The pathogen dynamic prediction module takes the pathogen transmission risk factors and the pathogen clinical environment transmission characteristics as input into the pathogen dynamic prediction model to obtain the epidemic trend guidance parameters of the pathogen within a set time in the future; The management strategy formulation module formulates corresponding pathogen management strategies based on the epidemic trend guidance parameters of pathogens.
Citation Information
Patent Citations
Precise control method for typhoid and paratyphoid intestinal infectious disease epidemic situation
CN108461155A
Metagenome-based clinical important pathogenic bacterium virulence gene detection method and system
CN113223618A
Method and device for predicting transmission risk of insect-borne infectious diseases, electronic equipment and medium
CN116721781A
Metagene sequencing result analysis method, device and equipment and storage medium
CN117079718A
Microbial infection risk prediction method and system based on gene detection
CN117649948A
Cited By
Comprehensive prevention and control method for parasites and pathogenic bacteria in pig breeding manure
CN120108772A
